CFH and LOC387715/ARMS2 genotypes and antioxidants and zinc therapy for age-related macular degeneration

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.10, 2008-10, pp. : 1547-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

An update on photodynamic therapy in age-related macular degeneration

By Rechtman Ehud Ciulla Thomas A Criswell Mark H Pollack Ayala Harris Alon

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

Dietary antioxidants and antioxidant supplements do not appear to be effective for the primary prevention of age-related macular degeneration

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

By Lacour M.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite